marialucia gallorini
Department of Pharmacy, University of Studies G. d'Annunzio Chieti and Pescara
Chieti, Italy
Review Editor
Anti-Cancer Drugs
Department of Pharmacy, University of Studies G. d'Annunzio Chieti and Pescara
Chieti, Italy
Review Editor
Anti-Cancer Drugs
University of Tübingen
Tübingen, Germany
Review Editor
Technologies and Strategies to Enable Drug Discovery
Columbia University
New York City, United States
Review Editor
Neurological Drugs
Jinan University
Guangzhou, China
Review Editor
Anti-Cancer Drugs
Institute of Biomedical Research, National Autonomous University of Mexico
Mexico City, Mexico
Review Editor
Anti-Cancer Drugs
Ensenada Institute of Technology
Ensenada, Mexico
Review Editor
Anti-Infective Agents
Institute of Physical Sciences, National Autonomous University of Mexico
Cuernavaca, Mexico
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Humanitas Research Hospital
Rozzano, Italy
Review Editor
Dermatologic Drugs
University of Petroleum and Energy Studies
Dehradun, India
Review Editor
Technologies and Strategies to Enable Drug Discovery
Indore Institute of Pharmacy (IIP)
Rau, India
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Federal University of Rio Grande do Norte
Natal, Brazil
Review Editor
Neurological Drugs
Shanghai University of Traditional Chinese Medicine
Shanghai, China
Review Editor
Anti-Cancer Drugs
Shanghai University of Traditional Chinese Medicine
Shanghai, China
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Universidade Federal de Ouro Preto
Ouro Preto, Brazil
Review Editor
Technologies and Strategies to Enable Drug Discovery
University of Buea
Buea, Cameroon
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
University of Derby
Derby, United Kingdom
Review Editor
Anti-Cancer Drugs